Controversies and ethical issues in cancer-genetics clinics
- 1 May 2005
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (5) , 301-310
- https://doi.org/10.1016/s1470-2045(05)70166-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The "Duty to Warn" a Patient's Family Members About Hereditary Disease RisksJAMA, 2004
- Genetic counseling program in familial breast cancer: Analysis of its effectiveness, cost and cost‐effectiveness ratioInternational Journal of Cancer, 2004
- Ethical, Legal, and Social Implications of Genomic MedicineNew England Journal of Medicine, 2003
- American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2003
- Medical geneticists' duty to warn at‐risk relatives for genetic diseaseAmerican Journal of Medical Genetics Part A, 2003
- Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal CancerAnnals of Internal Medicine, 2001
- Personal paper: Late onset genetic disease: where ignorance is bliss, is it folly to inform relatives?BMJ, 1998
- A cost-effectiveness analysis of colorectal screening for hereditary nonpolyposis colorectal carcinoma gene carriersCancer, 1998
- Professional Disclosure of Familial Genetic InformationAmerican Journal of Human Genetics, 1998
- Attitudes towards cancer predictive testing and transmission of information to the family.Journal of Medical Genetics, 1996